A Single Dose Clinical Trial to Study the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK1006.

Trial Profile

A Single Dose Clinical Trial to Study the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK1006.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Dec 2014

At a glance

  • Drugs Bekanamycin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Apr 2009 Patient numbers amended from 24 to 16 as reported by ClinicalTrials.gov.
    • 07 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Apr 2009 Actual initiation date changed from May 2008 to Apr 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top